PARP1 and non-small cell lung carcinoma: Two studies have shown that PARP1 is highly expressed in small-cell lung cancer cell lines at the mRNA and protein levels in the USA, and SCLC cell lines was significantly more sensitive to PARP inhibitors than were NSCLC cell lines [44, 54].